Various types of polycyclic aromatic compounds (PACs) in diesel exhaust particles are thought to contribute to carcinogenesis in mammals. Although the carcinogenicity, mutagenicity and tumourinitiating activity of these compounds have been evaluated, their tumour-promoting activity is unclear. In the present study, to determine the tumour-inducing activity of PACs, including previously known mutagenic compounds in atmospheric environments, a transformation assay for promoting activity mediated by the release of contact inhibition was conducted for six polycyclic aromatic hydrocarbons (PAHs), seven oxygenated PAHs (oxy-PAHs) and seven nitrated PAHs 
Introduction
The atmospheric environment contains various types of compounds from exhaust gas and particulate matter emitted from internal combustion engines, such as those in industrial factories, combustion furnaces and automobiles (1, 2) . Several epidemiological studies have identified an association between diesel exhaust particles (DEPs) and the occurrence of cancers of the lung and other organs (3) . DEPs contain various types of polycyclic aromatic compounds (PACs) that are thought to be the principle active factors responsible for the carcinogenicity of DEPs. To date, a large amount of data regarding the mutagenicity, carcinogenicity and DNA adduct formation with PACs have been accumulated (4) (5) (6) (7) (8) Along with PAHs, oxygenated PAHs (oxy-PAHs), such as polycyclic aromatic quinones and polycyclic aromatic ketones, are present as PACs in atmospheric diesel exhaust and airborne particles (8) (9) (10) (11) (12) . However, the toxicological significance of these compounds is not well understood (7, 13, 14) . Several studies have reported that polycyclic aromatic quinones induce severe adverse biological effects such as allergic inflammation and disruption of vascular tone via induction of the reactive oxygen species (ROS) pathway (15) (16) (17) (18) (19) .
Nitrated PAHs (nitro-PAHs) are originally emitted from various combustion engines and are more likely to be formed by the reaction of parental compounds with nitrogen dioxide in ambient air (20) . Nitro-PAHs are well-known bacterial direct-acting mutagens and carcinogens for mammals (2, 6, 21, 22) . Nitro-PAHs, such as 1-nitropyrene (1-NPy), 1,6-dinitropyrene (1,6-DNPy), 1,8-dinitropyrene (1,8-DNPy) and 6-nitrochrysene (6-NChr), have been categorised as probable carcinogens by IARC (5, 21) . Enya et al. identified a new nitrated oxy-PAH, 3-nitro-7H-benz [de] anthracen-7-one (3-NBAO), as a novel potent mutagenic and carcinogenic compound in the polar fraction of DEPs (23) (24) (25) , and the compound has been categorised to be a probable carcinogen by IARC (21) . Several other mutagenic nitrated oxy-PAHs and normal nitro-PAHs have been reported to possibly contribute to the mutagenic activity of environmental samples (26) (27) (28) .
Although many studies have reported on the carcinogenic and mutagenic activity of the above-mentioned PACs, studies regarding the tumour-promoting activity of these compounds are limited (29, 30) . Therefore, the underlying mechanisms promoting these activities have not completely been elucidated. Recently, a simple assay to detect the carcinogenic promoting activities of test compounds was developed by Ohmori et al. (31) using mouse embryonic fibroblasts (BALB/3T3 cells) transfected with the v-Ha-ras gene (Bhas 42 cells). Using this assay, several PACs, including B[a]A, Chr and 1-NPy, were found to have significant tumour-promoting activities. This indicates that other PACs, which have yet to be evaluated, are very likely to show positive responses using this assay (29) .
Several compounds are known to promote tumour formation, including ROS-producing compounds such as arsenic compounds, metal (cadmium and zinc) chlorides and catechol, which exhibited tumour-promoting activities as determined by the Bhas 42 assay as well as others (30) . Dioxins were also reported to exhibit tumourpromoting activities via mechanisms that included cell cycle regulation that correlated with aryl hydrocarbon receptor (AhR)-mediated gene induction activity (32) (33) (34) . Because several PAHs (35) (36) (37) , nitro-PAHs (37, 38) and polycyclic o-quinines (39) are known to promote AhR-mediated gene transcription activities to induce the production of metabolic enzymes such as cytochromes (CYPs), it is plausible that several PACs with high AhR-mediated gene transcription activities have high tumour-promoting activities.
In addition, Misaki et al. (40) examined AhR-mediated transcriptional activity induced by several types of oxy-PAHs to promote metabolic enzyme induction and reported for the first time that several oxy-PAHs [i.e. benzo (41) . These compounds were also shown to induce antioxidant response element (ARE)-mediated aldo-keto reductase family 1 gene (AKR1C1) (41) . Experimental results of the transcriptional activity of these compounds have been supported by numerous published reports of ROS induction by several nitro-PAHs (38, 42) , quinone compounds (15) (16) (17) (18) (19) 42) and PAH metabolites (15, 38, 42) .
Taken together, the findings of these previous studies suggest that several PACs with high AhR and/or ROS-inducing activities may be good candidates as tumour-promoting compounds. Therefore, in the present study, a transformation assay with Bhas 42 cells was used to identify the tumour-promoting activities of PACs (six PAHs, seven oxy-PAHs and seven nitro-PAHs) in the atmosphere to test the above-mentioned hypothesis. CYP1A1 mRNA levels induced via the AhR system and/or antioxidant signalling [heme oxygenase (HO)-1] of representative compounds were also analysed to determine whether signal transduction is relevant to the tumour-promoting activities of the selected compounds. (43, 44) , purified by column chromatography, and then recrystallised. The purities of the synthesised compounds were >99%. The 3-NBAO was prepared by nitration of benzanthrone, as described previously (24) .
Materials and methods

Chemicals
Minimum essential medium (MEM), Dulbecco's modified Eagle's medium/Ham's F12 (DMEM/F12) and fetal bovine serum (FBS) were purchased from Nissui Pharmaceutical Co., Ltd. (Tokyo, Japan), Life Technologies (Carlsbad, CA, USA) and Hana-Nesco Bio Corp. (Tokyo, Japan), respectively. The RNA extraction reagent was purchased from Qiagen (Valencia, CA, USA). Dimethyl sulfoxide (DMSO) was purchased from Wako Pure Chemical Industries, Ltd.
Bhas 42 cell culture
The mouse fibroblast cell line Bhas 42 was obtained from the Health Science Research Resources Bank (Sennan, Osaka, Japan). The cells were incubated in MEM with 10% (v/v) FBS at 37°C in a humidified atmosphere containing 5% CO 2 . The cells were sub-cultured before reaching confluence.
Transformation assay to detect tumour-promoting activity
Tumour-promoting activity was evaluated using a transformation assay, as described previously (29, 30) . In brief, 4 × 10 4 Bhas 42 cells in 2 ml of DMEM/F12 with 5% FBS were cultured in each well of six-well microplates (Day 0). The medium was changed with fresh medium containing the test chemicals on Days 3, 7 and 10 after the initial harvest and then treated with only fresh medium on Day 14. On Day 21, the cells were fixed with methanol and stained with 5% Giemsa solution. All the chemicals were dissolved in DMSO and the final concentration of the solvent in the culture medium was 0.1% (v/v). Control cells were treated with 0.1% (v/v) DMSO. Cell cultures were prepared in triplicate for each chemical at each concentration.
The number of foci in each well was based on the morphological criteria used in a previous study (31) as follows: (i) deep basophilicity, (ii) dense multi-layering of cells, (iii) random orientation of cells at the edge of foci and (iv) ≥20 cells within a focus. If a significant increase in focus number with a P value of <0.01 was observed at ≥1 concentration, or a significant increase with a P value of <0.05 was observed at ≥2 serial concentrations by the Dunnett test analysis, the chemical was regarded as positive. If ≥10 foci were confirmed following exposure to <100 nM for a positive chemical, the chemical was regarded as a powerful positive. If a significant increase in focus number with a P value of <0.05 was observed at only one concentration, the chemical was regarded as equivocal. If there was no significant increase in focus number at any concentration, the chemical was regarded as negative.
Cell viability assay
Cell viability in response to each chemical was examined using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt (MTS) assay, basically according to the manufacturer's protocol (45) . Cells were cultured in each well of 24-well microplates by adjusting the cell numbers to 1 × 10 4 cells in 500 μl of DMEM/F12 with 5% FBS. On Day 3, the medium was changed to fresh medium containing a test chemical. On Day 7, 100 μl of MTS solution was added to the medium, and after 4 h, optical density at 490 nm was measured using a plate reader (ARVO™ X3; PerkinElmer, Inc., Waltham, MA, USA).
RNA isolation, reverse transcription and real-time polymerase chain reaction
Cells were cultured in each well of six-well microplates by adjusting the cell numbers to 4 × 10 4 cells in 2 ml of DMEM/F12 with 5% FBS. On Day 3, the cells were treated for 24 h with medium containing a test chemical. On Day 4, total RNA was isolated from the cells using the RNeasy Mini Kit (Qiagen) and DNA-Free™ Kit (Applied Biosystems, Foster City, CA, USA), according to the manufacturers' protocols. Total RNA was dissolved in RNase-free water and the concentration was determined spectrometrically. Cell cultures were prepared in triplicate for each chemical.
Total RNA (100 ng) was added to a reaction mixture containing 100 pmol of random hexamers, Prime Script® RT Enzyme Mix and deoxyribonucleoside triphosphates in a final volume of 20 μl and reverse transcribed using the Prime Script® RT Reagent Kit (Perfect Real Time) (Takara Bio, Inc., Otsu, Japan). The reaction mixture was incubated at 37°C for 15 min and heated at 85°C for 5 min to inactivate the enzyme according to the manufacturer's protocol.
The following previously reported oligonucleotides used for polymerase chain reaction (PCR) were commercially synthesised by Sigma-Aldrich Japan (Ishikari, Japan) (46-48):
Quantification of cDNA was performed using the ABI PRISM 7900HT Sequence Detection System (Applied Biosystems), and staining was performed with SYBR Green I. A 2 μl aliquot of the reverse transcription (RT) mixture was added to a PCR mixture containing 0.2 μM of each primer and SYBR® Premix Ex Taq DNA polymerase in a final volume of 25 μl and amplified using the SYBR® Premix Ex Taq™ Kit (Perfect Real Time) (Takara Bio, Inc.) according to the manufacturer's protocol. The PCR reactions were performed with 1 cycle at 95°C for 30 s and 40 cycles of 95°C for 5 s and 65°C for 30 s. The specificity of the PCR products was determined by a melting curve analysis and expression levels were normalised against 18S rRNA levels. A significant increase (P < 0.05) of fold induction, namely the ratio of the normalised value in PAC-treated cells divided by the value in DMSO control cells, was evaluated using the Student's t-test. 
Results
Tumour-promoting activities of PACs
In the present study, a transformation assay to evaluate tumourpromoting activity using Bhas 42 cells was performed for 6 PAHs, 7 oxy-PAHs and 7 nitro-PAHs, which exist in DEPs (Figure 1) . The tumour-promoting activity was statistically significant (P < 0.05) when ≥8 foci were detected. The representative promoter TPA significantly increased the number of foci within the range of 8-160 nM (Figure 2 Figure 2G and I) . For the PACs, the tumour-promoting activity of Chr was considered medium while that of 1-NPy and benzo[e]pyrene (B[e]P) was low (Figure 2A and G), confirming the results of a previous study (29) . The activity of B[a]P was not significant in this assay (Figure 2A ), although the activity was reported as equivocal (29) . No tumour-promoting activities could be detected for DB[a,l]P and phenanthrenequinone (PhQ) (Figure 2A and C) . In an MTS assay, DB[a,l]P, PhQ, NphQ, 6-NChr and 3-NBAO exhibited a markedly greater decrease in cell viability ( Figure 2B, D and J) .
Induction of mRNA of metabolic enzymes after exposure to PAHs and oxy-PAHs
To investigate the molecular mechanisms of tumour-promoting activity, we analysed the amounts of CYP1A1 and HO-1 mRNA in Bhas 42 cells induced with representative active compounds by 24 h incubations (the time point predicted to reflect their promoting activity and metabolism based on previous studies) (35) (36) (37) 49, 50) (Figure 3 ). The ratio of CYP1A1 and HO-1 mRNA levels to 18S Figure 2 . Tumour-promoting activity and cell viability of PACs. The tumour-promoting activities of (A) PAHs, (C and E) oxy-PAHs and (G and I) nitro-PAHs were measured using Bhas 42 cells. Cell viability for (B) PAHs, (D and F) oxy-PAHs and (H and J) nitro-PAHs in Bhas 42 cells was also examined. Double asterisks indicates highly significant differences from controls (P < 0.01) and single asterisk indicates significant differences from controls (P < 0.05), as determined by a Dunnett test.
rRNA of DMSO-treated control cells was 4.4 × 10 −2 and 9.7 × 10 −1 , respectively. Importantly, the concentration of compounds exposed to cells for mRNA detection was within the range 200 nM to 1 μM, in which significant tumour-promoting activity was detected using the Bhas 42 assay. CYP1A1 mRNA was induced by each of these compounds ( Figure 3A Figure 3B ). There was no significant change in induction levels of two oxy-PAHs (NphQ and B[b]FO) in comparison with the control. The present results (promoting activity) and previous toxic data, including AhR activity and CYP1A1 induction in hepatoma cells, are summarised in Table 1 .
Discussion
Cancer is thought to be the result of several processes: initiation by exposure to mutagens, immortalisation, release of contact inhibition, acquisition of anchorage-independent growth, migration and metastasis ability. The release of contact inhibition is the most important step in the promotion process. In the present study, a transformation assay with Bhas 42 cells transfected with the H-ras gene from immortalised mouse foetus fibroblasts (BALB/3T3 cells) with contact inhibition abilities was used to assess the tumour-promotion process (29) (30) (31) 51) . Using this cell line, Asada et al. (29) detected tumourpromoting activity for B[a]A, Chr, B[e]P and 1-NPy. We also measured the tumour-promoting activity of the last three compounds and obtained comparable results, demonstrating that our experimental system is reproducible (Figure 2A and G) . We evaluated the tumourpromoting activities of 16 other PACs for the first time (Figure 2) .
The tumour-promoting activities of cells have been suggested to be mediated via the AhR-mediated pathway. Dietrich and Kaina (32) proposed that the release of cell-cell contact inhibition by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and PAHs was caused by cyclin A/cdk2-dependent cell cycle progression, mainly downstream of pRB with upregulation of p27 via AhR-mediated upregulation of cyclin A protein levels. They also suggested a potential role of AhR in the downregulation of E-cadherin (adherence junction), leading to epithelial-mesenchymal transition (EMT) and tumour progression (32) . It was also suggested that the inhibition of gap junctional intercellular communication (GJIC) was in response to the downregulation of connexin levels via AhR activation in rat liver WB-F344 cells (34) . In Bhas 42 cells, the decrease in GJIC and other contact inhibition systems may be caused by the AhR-mediated deregulation of genes related to intercellular adhesion following exposure to PACs. TCDD was also reported to disrupt the regulation of cell proliferation and apoptosis via several genes (p53, p27, cyclins, TGF-β, Ras and others) via AhR (32,33,52-54). Thus, AhR-mediated deregulation of cell growth and apoptosis may be the source of the tumourpromoting activity of Bhas 42 cells exposed to AhR-active PACs.
In the present study, we found for the first time (Table 1) (35, 40, 41) . AhR-mediated intermediate gene transcription activities have also been found for several oxy-PAHs, including NphQ and B[b]FO, using the CALUX assay and the CYP mRNA induction assay with HepG2 cells (39) (40) (41) . It was predicted that many of the PACs inducing CYP mRNA in such hepatoma cells have tumour-promoting activities. Previous studies have exhibited a significant induction of CYPs by 6-NChr, dinitropyrenes, 3-NFA and 3-NBAO in human tissue-derived cells (21, 37, 38) . In the present study, the tumour-promoting activities of these nitro-PAHs in Bhas 42 cells ( Figure 2G ) may have been mediated by AhR, particularly 6-NChr, which produced a high amount of CYPs.
The amount of CYP1A1 mRNA in response to a BPO treatment was only 2-fold greater than that of the DMSO-treated controls at the concentration at which significant tumour-promoting activity (increased number of foci) was confirmed ( Figures 2E and 3A) . However, in a previous study the induction of CYP1A1 mRNA in HepG2 cells was inhibited by 5 μM BPO (under half of the amount of the control) (41) . Although differences in cell responses may be due to different amounts of metabolic enzymes and/or treated chemical concentrations, BPO seemed to be a weak inducer for CYP1A1 mRNA expression. Therefore, the powerful tumour-promoting activity of BPO could not be explained by only CYP1A1 mRNA induction but could be dependent on another pathway. PAHs and oxy-PAHs. Bhas 42 cells were exposed to chemicals for 24 h at concentrations at which significant tumour-promoting activities are known to be detected for these compounds (range 200 nM to 1 μM). (A) CYP1A1 mRNA and (B) HO-1 mRNA levels were measured. Double asterisks indicates highly significant differences from controls (P < 0.01) and single asterisk indicates significant differences from controls (P < 0.05), as determined by a Student's t-test.
Many ROS-producing metals, metalloids and catechol exhibit tumour-promoting activities (30) and regulate cell proliferation (55) . ROS are reported to regulate protein kinase C (PKC) and protein tyrosine phosphatase (PTP) followed by mitogen-activated protein kinase (MAPK) activation and E-cadherin regulation, leading to EMT (56) . Several nitro-PAHs (38, 42) and quinone compounds (15) (16) (17) (18) (19) 38, 42, 57) have been reported to induce ROS production. Several quinones have been reported to inhibit PKC, a regulator of cell proliferation and tumour promotion (58) . Several oxy-PAHs express ARE-mediated enzymes such as AKR1C1 (15, 41) . Therefore, the high tumour-promoting activity of BPO could be induced via AREs, considering the RT-PCR results for HO-1 mRNA in Bhas 42 cells (Figures 2E and 3B) . It has been reported that several PAHs were metabolically activated to form ROS-generating metabolites, and before that ARE-mediated gene activation (AKR1C1 mRNA) was induced by many PAHs in HepG2 cells (41) . Hence, the tumourpromoting activities of B[k]FA and B[b]FA may be partly mediated by the ARE pathway (Figures 2A and 3B) .
B[a]P, DB[a,h]A and DB[a,l]P are known to have powerful carcinogenic potency, probably resulting from their DNA adduct formation abilities followed by their mutation inducibility (Table 1) (4, 5, 7) . Repeated doses of B[a]P and 3-methylcholanthrene have been reported to promote tumour development (59) . Strong initiating activities for these compounds were found by Asada et al. although no tumour-promoting activities were confirmed using Bhas 42 cells (29, 30) . It is thought that the tumour development and initiating activities of Bhas 42 cells result from the fixation and accumulation of genetic damage after cell divisions (29) . Whereas in the present study, DB[a,l]P and PhQ showed no tumour-promoting activity and B[a]P exhibited no significant activity though both CYP1A1 and HO-1 mRNA were significantly induced (Figures 2A,  C and 3) . These results may have been caused by growth arrest and apoptosis following the accumulation of DNA adducts and oxidative stress (Figure 2B and D) . In rat liver WB-F344 (60) and cancerous human lung A549 cells (61) , an increase in cell proliferation at low concentrations was reported for DB[a,l]P, PhQ and NphQ which exhibited cytotoxicity (significant decrease of cell proliferation) at high concentrations. In comparison with these cells, Bhas 42 cells are more sensitive to cytotoxicity, and an increase in cell proliferation could not be detected at low concentration levels for these acutely toxic compounds (Figure 2B and D) . In Figure 3 , the induction of CYP1A1 and HO-1 mRNA in treated cells at 24 h was predicted to be reflected by AhR-mediated and oxidative signalling of the compounds themselves or their metabolites, respectively, even if they were cytototoxic (39, 40) . Epidermal hyperplasia associated with the induction of cytokines and hypersensitivity was required for tumour promotion in mouse skin exposed to DB[a,l]P at low concentrations (62); however, this promoting effect could not be evaluated with Bhas 42 cells in the present study. Tumour-promoting activities were detected for many compounds in the present study, as reflected by the release from contact inhibition via the dysregulation of signal transduction (32) (33) (34) (52) (53) (54) (55) (56) 58) , although an accumulation of genetic damage may be partially responsible. It was thought that the contribution of genetic damage was limited to tumour-promot- Table 1 ), which are not or only slightly mutagenic (7, 13) .
The tumour-promoting activities of these compounds may be mediated by other receptors and signal transduction pathways (63) (64) (65) (66) . For example, it has been demonstrated that non-dioxinlike polychlorinated biphenyls (PCBs) may activate tumour promotion in liver epithelial cells via the constitutive androstane receptor (CAR) with the degradation of E-cadherin (adherence junction) and inhibition of Wnt/β-catenin/Tcf signalling (65, 66) . Interactions of other nuclear receptors with Wnt/β-catenin/Tcf signalling and their effects on adhesion, morphogenesis and oncogenesis have been reviewed (63) , and tumour promoters in liver cells acting through the peroxisome proliferator activated receptor α have also been reported (65) .
In summary, we found that B[k]FA, B[b]FA, BPO, 3-NBAO and 6-NChr had powerful tumour-promoting activities and most of the other oxy-PAHs and nitro-PAHs also exhibited these activities when using Bhas 42 cells. It was predicted that many of these compounds induced CYP1A1 or HO-1 mRNA in Bhas 42 cells. Accordingly, AhR activity or antioxidant signalling may be relevant to the tumour-promoting activities of these compounds on release from contact inhibition. Several studies have identified genes related to the promotion of cell growth and tumour induction, as demonstrated by transfection and knockdown of these genes in cellular and experimental animal models (67) (68) (69) (70) . We next plan to elucidate in detail the genes and mechanisms involved in the tumour-promoting activities of several PACs. Lübcke-von Varel et al. (71) showed the inhibition of GJIC in the polar fractions of sediment polluted with petroleum extracts. It is predicted that several polar PAH derivatives, such as oxy-PAHs, significantly contribute to tumour-promoting activities in the atmospheric environment surrounding industrial areas because of combustion. Future studies are warranted to identify the primary compounds that contribute to tumour-promoting activities of particulate matter in the atmospheric environment.
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